These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 35043499)

  • 1. Hypocretins (orexins): The ultimate translational neuropeptides.
    Jacobson LH; Hoyer D; de Lecea L
    J Intern Med; 2022 May; 291(5):533-556. PubMed ID: 35043499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Orexin in sleep, addiction and more: is the perfect insomnia drug at hand?
    Hoyer D; Jacobson LH
    Neuropeptides; 2013 Dec; 47(6):477-88. PubMed ID: 24215799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The hypocretins/orexins: integrators of multiple physiological functions.
    Li J; Hu Z; de Lecea L
    Br J Pharmacol; 2014 Jan; 171(2):332-50. PubMed ID: 24102345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of hypocretin attenuates behavioral changes produced by glutamatergic activation of the perifornical-lateral hypothalamic area.
    Kostin A; Siegel JM; Alam MN
    Sleep; 2014 May; 37(5):1011-20. PubMed ID: 24790280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The orexin story, sleep and sleep disturbances.
    Pizza F; Barateau L; Dauvilliers Y; Plazzi G
    J Sleep Res; 2022 Aug; 31(4):e13665. PubMed ID: 35698789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypocretin (Orexin) Replacement Therapies.
    Seigneur E; de Lecea L
    Med Drug Discov; 2020 Dec; 8():. PubMed ID: 38738170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Almorexant promotes sleep and exacerbates cataplexy in a murine model of narcolepsy.
    Black SW; Morairty SR; Fisher SP; Chen TM; Warrier DR; Kilduff TS
    Sleep; 2013 Mar; 36(3):325-36. PubMed ID: 23449602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypocretin-2-saporin lesions of the lateral hypothalamus produce narcoleptic-like sleep behavior in the rat.
    Gerashchenko D; Kohls MD; Greco M; Waleh NS; Salin-Pascual R; Kilduff TS; Lappi DA; Shiromani PJ
    J Neurosci; 2001 Sep; 21(18):7273-83. PubMed ID: 11549737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypocretin (orexin): role in normal behavior and neuropathology.
    Siegel JM
    Annu Rev Psychol; 2004; 55():125-48. PubMed ID: 14744212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The brain hypocretins and their receptors: mediators of allostatic arousal.
    Carter ME; Schaich Borg J; de Lecea L
    Curr Opin Pharmacol; 2009 Feb; 9(1):39-45. PubMed ID: 19185540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The sleep-wake cycle, the hypocretin/orexin system and narcolepsy: advances from preclinical research to treatment.
    Arias-Carrión O; Bradbury M
    CNS Neurol Disord Drug Targets; 2009 Aug; 8(4):232-4. PubMed ID: 19689304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypocretin-1 modulates rapid eye movement sleep through activation of locus coeruleus neurons.
    Bourgin P; Huitrón-Résendiz S; Spier AD; Fabre V; Morte B; Criado JR; Sutcliffe JG; Henriksen SJ; de Lecea L
    J Neurosci; 2000 Oct; 20(20):7760-5. PubMed ID: 11027239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of intranasal hypocretin-1 (orexin A) on sleep in narcolepsy with cataplexy.
    Baier PC; Hallschmid M; Seeck-Hirschner M; Weinhold SL; Burkert S; Diessner N; Göder R; Aldenhoff JB; Hinze-Selch D
    Sleep Med; 2011 Dec; 12(10):941-6. PubMed ID: 22036605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A circuit perspective on narcolepsy.
    Adamantidis AR; Schmidt MH; Carter ME; Burdakov D; Peyron C; Scammell TE
    Sleep; 2020 May; 43(5):. PubMed ID: 31919524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypocretin/orexin overexpression induces an insomnia-like phenotype in zebrafish.
    Prober DA; Rihel J; Onah AA; Sung RJ; Schier AF
    J Neurosci; 2006 Dec; 26(51):13400-10. PubMed ID: 17182791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypocretin (orexin) deficiency in narcolepsy and primary hypersomnia.
    Ebrahim IO; Sharief MK; de Lacy S; Semra YK; Howard RS; Kopelman MD; Williams AJ
    J Neurol Neurosurg Psychiatry; 2003 Jan; 74(1):127-30. PubMed ID: 12486284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Orexin: clinical and therapeutic implications].
    Mediavilla C; Risco S
    Rev Neurol; 2014 Feb; 58(3):117-24. PubMed ID: 24469938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in understanding the roles of hypocretin/orexin in arousal, affect, and motivation.
    Nevárez N; de Lecea L
    F1000Res; 2018; 7():. PubMed ID: 30254737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The hypocretin/orexin receptor: therapeutic prospective in sleep disorders.
    Nishino S
    Expert Opin Investig Drugs; 2007 Nov; 16(11):1785-97. PubMed ID: 17970638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypocretin (orexin) is critical in sustaining theta/gamma-rich waking behaviors that drive sleep need.
    Vassalli A; Franken P
    Proc Natl Acad Sci U S A; 2017 Jul; 114(27):E5464-E5473. PubMed ID: 28630298
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.